capital markets

$AMFN appoints 30-year finance veteran Michael Carlson as CFO, completes independent audits, and files Form 10 with SEC.

Investec becomes first institutional member of FCA-authorised BPX digital securities marketplace, integrating via ZebrA-X platform. Partnership signals institutional adoption of tokenised asset infrastructure.

Kevin K. Albert, 40-year Wall Street veteran, joins Vintage Stone Capital as Senior Partner to scale industrial acquisition strategy in lower middle-market segment.

Crédit Agricole issues €228.5M senior bonds at 3.40% maturing 2036 while its Ukraine subsidiary acquires Bank Lviv, strengthening regional presence and capital position.

$RNWF completes PCAOB audit, files Form 10 with SEC. Pursuing OTCQB qualification and exploring national exchange listing with investment banking discussions ongoing.

Stifel hires veteran bankers Pathak and Reisner as Managing Directors to lead new healthcare banking practice, targeting hospitals and health systems.

Galaxy Corporation hosts Nasdaq VP in Seoul, reports H1 2025 revenue of KRW 126 billion with 200%+ YoY growth and returned profitability amid U.S. listing plans.

Cohen & Company reports explosive 246% revenue growth to $275.6M in 2025, with investment banking division closing $43B in transactions and commanding SPAC IPO market leadership.

CDT Equity acquires 20% stake in Sarborg AI for $115M while advancing AstraZeneca-licensed pharmaceuticals and exploring capital markets options.

Prediction market platform Polymarket could IPO in 2026 amid sector enthusiasm, but historical precedent suggests peak-hype IPOs significantly underperform.

BrightSpring announces $823M secondary stock offering at $41.15/share with concurrent $60M repurchase, closing March 4.

SEDA Experts LLC hires John Hardt as Managing Director, leveraging his 40+ years at Goldman Sachs, UBS, Citigroup, and other major banks.

GLPI priced $800M senior notes at 5.625% coupon to refinance debt and fund strategic initiatives, settling March 2026.

Kyverna appoints two biotech executives to its board ahead of cell therapy commercialization. New directors bring expertise from Beam Therapeutics and Karuna Therapeutics.

Pandora insiders and BlackRock expand shareholdings, signaling continued confidence in the jewelry manufacturer's strategic positioning and business trajectory.

Xtreme One Entertainment uplifts to OTCQB market, improving accessibility and visibility. The move enhances institutional profile and investor participation for the entertainment company.

Integrated Rail & Resources files confidential S-1 registration for public listing and names Chris Greenwood as new CFO with relevant industry experience.

Morgan Stanley-backed Zest Equity launches two FSRA-regulated services—Zest Arrange and Zest Escrow—to streamline private market transactions alongside its existing SPV formation capabilities.